Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Restructuring Costs: 2018-2021

Historic Restructuring Costs for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Sep 2021 value amounting to -$73,000.

  • Ironwood Pharmaceuticals' Restructuring Costs fell 105.93% to -$73,000 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.2 million, marking a year-over-year decrease of 22.05%. This contributed to the annual value of $15.4 million for FY2020, which is 325.41% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Restructuring Costs stood at -$73,000 for Q3 2021, which was up 74.11% from -$282,000 recorded in Q2 2021.
  • Over the past 5 years, Ironwood Pharmaceuticals' Restructuring Costs peaked at $10.1 million during Q3 2018, and registered a low of -$282,000 during Q2 2021.
  • Its 3-year average for Restructuring Costs is $601,000, with a median of $139,500 in 2019.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Restructuring Costs surged by 842.17% in 2020 and then crashed by 105.93% in 2021.
  • Ironwood Pharmaceuticals' Restructuring Costs (Quarterly) stood at $705,000 in 2018, then plummeted by 104.54% to -$32,000 in 2019, then soared by 842.17% to $1.2 million in 2020, then crashed by 105.93% to -$73,000 in 2021.
  • Its last three reported values are -$73,000 in Q3 2021, -$282,000 for Q2 2021, and $311,000 during Q1 2021.